publication date: May. 17, 2019
In Brief Hollings Cancer Center receives NCI-designation renewal
Hollings Cancer Center of the Medical University of South Carolina received re-designation as an NCI Cancer Center.
The renewal is accompanied by $10.8 million in funding. Hollings has held this designation since 2009.
“This took an enormous effort from a large group of team members to be able to present and highlight the excellence at Hollings to the NCI leadership,” Hollings Cancer Center Director Gustavo Leone said in a statement. “We want to reach the medically underserved all through the state. While there is much work still to be done, this has been a major accomplishment over the past several years that has led to the appreciation of the NCI of what we are doing in our communities, and the value we bring.”
Key accomplishments since Hollings’ last renewal include:
Opening 392 cancer-related research studies and enrolled 3,522 adults and children in clinical trials (2014-2017)
Expanding mobile health van cancer screening and education to 27 counties throughout the state, serving more than 7,000 women in the past five years
Launching 42 clinical trials emanating from Hollings Cancer Center science (2013-2017)
Securing 138 peer-reviewed, extramural research project awards totaling over $40M (excluding training and career development grants), with more than $20M from the NCI in 2018.
Publishing … Continue reading Hollings Cancer Center receives NCI-designation renewal
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.